Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-24-000020
Filing Date
2024-11-07
Accepted
2024-11-07 07:39:06
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q carm-20240930.htm   iXBRL 10-Q 1424877
2 EX-31.1 carm-20240930xexx311.htm EX-31.1 10679
3 EX-31.2 carm-20240930xexx312.htm EX-31.2 10676
4 EX-32.1 carm-20240930xexx321.htm EX-32.1 4994
5 EX-32.2 carm-20240930xexx322.htm EX-32.2 4989
  Complete submission text file 0001485003-24-000020.txt   5607741

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT carm-20240930.xsd EX-101.SCH 43221
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT carm-20240930_cal.xml EX-101.CAL 54704
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT carm-20240930_def.xml EX-101.DEF 111359
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT carm-20240930_lab.xml EX-101.LAB 572552
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT carm-20240930_pre.xml EX-101.PRE 352869
67 EXTRACTED XBRL INSTANCE DOCUMENT carm-20240930_htm.xml XML 493547
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 241433227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)